Novartis, CH0012005267

Novartis stock trades at EUR 127.22 with USD 269.9 billion market cap

Published on 10/08/2026 at 15:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Novartis stock trades at EUR 127.22 on October 8, 2026. Market value was USD 269.9 billion and P/E was 21.81 in the latest quote.

Aquarell der Basler Altstadt mit Rheinbrücke und Münster in weichen Pastellfarben — Novartis AG CH0012005267 – Aquarell Basels mit Rheinbrücke und Münster in zarten Pastelltönen, Illustration mit AI erstellt.

Novartis stock was trading at EUR 127.22 at Lang & Schwarz on October 8, 2026 at 3:37 p.m. CEST. The company lists its next quarterly reporting date as October 27, 2026, according to Novartis.

Intraday quote stays narrow

The Lang & Schwarz bid stood at EUR 127.20 and the ask at EUR 127.24 at 3:37 p.m. CEST, leaving a four-cent spread. The quote gives German investors a euro reference while the company's Swiss listing and US depositary receipt trade in separate currencies.

A separate US-dollar NVS quote on October 8, 2026 showed USD 141.98, a prior close of USD 143.28, volume of 259,776 shares and average volume of 1,963,882 shares. The session volume therefore stood at 13.23 percent of the stated average.

Range and valuation markers

The same US-dollar quote placed the 52-week range at USD 121.57 to USD 170.46. At USD 141.98, the price was 16.71 percent below the range high, calculated against USD 170.46.

Market capitalization was USD 269.9 billion on October 8, 2026, while the reported P/E ratio was 21.81. These figures describe the US-dollar NVS quote and are separate from the EUR 127.22 Lang & Schwarz reference.

Analyst target moves lower

According to Markets Insider on October 6, 2026, Morgan Stanley analyst Thibault Boutherin lowered the Novartis price target to USD 156 from USD 170 and kept an Overweight rating. The target change gives the valuation discussion a dated analyst reference, but its US-dollar basis cannot be compared directly with the euro quote.

Comparison with peers

Novartis: daily change, P/E 21.81, market capitalization USD 269.9 billion

Roche: daily change, P/E, market capitalization

SMI: daily change, P/E, market capitalization

Results date is October 27

Novartis has scheduled its third-quarter 2026 financial results for October 27, 2026, according to Novartis. The date is the next company-specific calendar marker for the stock and follows the second-quarter results published on July 21, 2026.

Market report and quote

Novartis was trading at EUR 127.22 at Lang & Schwarz on October 8, 2026 at 3:37 p.m. CEST, with a bid of EUR 127.20 and an ask of EUR 127.24. The real-time quote of Novartis stock provides the continuously updated trading view.